Thrombolytic treatment in diabetic patients with acute myocardial infarction: Lower rates of use than in non-diabetic patients are explained by differences in presenting ECGs

Heart

Volumn 90, Issue 11, 2004, Pages 1346-1347

  Kvan, Elena ^a,b   Reikvam, A ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ANGINA PECTORIS; ARTICLE; ATHEROSCLEROSIS; DIABETES MELLITUS; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORWAY; PRIORITY JOURNAL; SEX RATIO; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; STROKE;

AGED; DIABETIC ANGIOPATHIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS; THROMBOLYTIC THERAPY;

EID: 7244227792     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.026724     Document Type: Article

References (5)

1. Norhammar A, Malmberg K, Ryden L, et al. Under utilisation of evidence-based treatment partial explanation for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 2003;24:838-44.
2. Mak KH, Topal EJ. Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus. J Am Coll Cardiol 2000;35:563-8.
3. Reikvam A, Kvan E, Aursnes I. Use of cardiovascular drugs after acute myocardial infarction: a marked shift towards evidence-based drug therapy. Cardiovasc Drugs Ther 2002;16:451-6.
4. European Secondary Prevention Study Group. Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. Lancet 1996;347:1203-7.
5. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002;23:1809-40.